Respiratory Pathogen Testing Kits Market
Market Insights on Respiratory Pathogen Testing Kits covering sales outlook, demand forecast & up-to-date key trends
Respiratory Pathogen Testing Kits Market by Product, Infection/Symptom, Technology, End User & Region - Forecast 2022 - 2030
Respiratory Pathogen Testing Kits Market Outlook (2022-2030)
[235 Pages Report] Global consumption of respiratory pathogen testing kits is set to enjoy a valuation of US$ 3.85 Bn in 2022, and the market is slated to progress at a healthy CAGR of 6.1% to reach a valuation of US$ 6.16 Bn by 2030.
|
Respiratory Pathogen Testing Kits Market Size (2022) |
US$ 3.85 Bn |
|
Revenue Forecast (2030) |
US$ 6.16 Bn |
|
Global Market Growth Rate (2022-2030) |
6.1% CAGR |
|
Dominant Technology |
NAAT (Nucleic Acid Amplification) (44.6% Share) |
Respiratory pathogen testing kits currently account for 49.1% share in the global respiratory diagnostics market. The global respiratory pathogen kits market is predicted to rise rapidly due to an increase in the prevalence of respiratory disorders across the world.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
5.86% |
|
H1, 2022 Projected |
6.06% |
|
H1, 2022 Outlook |
5.96% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(+) 10 ↑ |
According to Future Market Insights' analysis, the global respiratory pathogen testing kits market expects to increase by 10 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 10 BPS.
The market for respiratory pathogen testing kits observes a decline in the BPS values with the limitations in rapid testing to not be able to evaluate common detection of coinfections. Moreover, testing kits pose limitations, such as a slow turnaround time, a labour-intensive processes, and low sensitivity.
However, with the emergence of respiratory pathogens (RP) panel tests, the market will experience an incline in terms of growth, owed to the high specificity of RP panel tests for different virus and bacteria in the respiratory tract.
The market is subject to changes as per the regulatory norms and product adoption rates, with respect to the macro and industry dynamics. The key developments in the market include the development of PCR based diagnostic test panels to detect and differentiate common respiratory pathogens simultaneously.
Respiratory Pathogen Testing Kit Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)
Sales of respiratory pathogen testing kits expanded at a rapid CAGR of 10.5% from 2015 to 2021.
By analysing blood, fluids, or a specimen from the diseased area of the body, a respiratory pathogen testing kit can be used to identify respiratory infections.
The genetic information (RNA/DNA) of some of the most prevalent infections is detected by respiratory pathogen testing kits. It can identify many bacteria that cause infection and find microbes that standard tests, such as cultures, can fail to find during testing. Some testing kits can detect microorganism subgroups or strains.
Respiratory tract blockage is caused by uncontrolled intake of various gases such as sulphur dioxide and carbon monoxide. Respiratory pathogen testing kits can diagnose a variety of bacterial, fungal, and viral infections in the respiratory system.
Lateral flow tests, also referred to as immunochromatographic assays, reverse transcription-polymerase chain reaction (RT-PCR) tests, direct fluorescent antibody (DFA) tests, solid-phase assays, agglutination assays, and flow-through assays are among the various types of respiratory pathogen testing.
Chronic Obstructive Pulmonary Disease (COPD) is a lung disease that causes a decline in airflow over time. As per WHO, low and middle-income nations account for 90% of COPD deaths.
According to the Global Burden of Disease study, around 251 million cases of chronic obstructive pulmonary disease were documented worldwide. It is predicted to rise over the coming years as the world's population ages and people's lifestyles change. Thus, as early identification and treatment are becoming necessary, the market for respiratory pathogen testing kits is expanding.
Demand for respiratory pathogen testing devices is predicted to progress at a healthy CAGR of 6.1% from 2022 to 2030, with the global market expected to close in on a valuation of US$ 6.16 Bn by 2030.
Which Aspects are Positively Influencing Demand for Respiratory Pathogen Testing Kits?
“Increasing Investments in R&D Boosting Sales of Respiratory Pathogen Testing Systems”
Market growth is boosted by increased funding for respiratory diagnostics.
- Mesa Biotech was acquired by Thermo Fisher in February 2021 in order to strengthen its Life Sciences Solutions business area. In 2021, this segment's revenue increased by almost US$ 200 million as a result of this transaction.
“Rising Incidence of Chronic Diseases Driving Consumption of Respiratory Pathogen Testing Equipment”
The respiratory pathogen testing devices market is predicted to develop due to the increased use of imaging technologies such as computed tomography (CT) in COPD diagnosis.
Use of technologically advanced equipment, such as pulse oximeters, for successful COPD care in outpatients, is quickly gaining traction. Also predicted to drive market expansion is the trend of non-invasive mechanical ventilation for COPD.
“Coronavirus Boosting Sales of Respiratory Pathogen Testing Kits”
Pneumonia, tuberculosis, bronchitis, influenza, tonsillitis, and the common cold are among the current medical disorders driving the market for respiratory pathogen testing kits. The COVID-19 pandemic has enhanced the market, since the number of covid cases continues to rise or fall at an alarming rate every day, depending on the state of health in each region.
It is critical to have respiratory pathogen testing equipment on hand to implement remedial measures within the required timeframe. Leading businesses and the respective government agencies are banding together to ensure that these kits are widely available.
“Need for Advanced Diagnostic Testing Methods Fuelling Demand for Respiratory Pathogen Testing Kits”
The diagnostic methods available to diagnose bacterial and viral illnesses in the current scenario are rapid molecular assays, antigen testing, immunofluorescence assays, vital culture, and RT-PCR (reverse transcription-polymerase chain reaction). Mylab, based in India, has developed the "PathoDetect Covid-19 Qualitative PCR kit."
This kit uses the RT-PCR method to detect infection within 2.5 hours, according to the manufacturer (as compared to 7.5 hours taken previously). This aspect is projected to boost demand for respiratory pathogen test kits in India and other Asia Pacific nations, as more infections can be discovered in much less time (considering the increasing number of incidences and population density in this region).
Staphylococcus Aureus, Moraxella Catarrhalis, Haemophilus Influenzae, and Streptococcus Pneumoniae are among the additional microorganisms that require effective respiratory pathogen testing kits. Apart from the methods stated above, multiplex PCR technology is being used since it provides fast and accurate respiratory pathogen detection.
Though viruses and bacteria account for the majority of respiratory pathogen testing kits sold, fungi also play a role. As a result, there will be an increase in demand for these kits all over the world.
"Rapid molecular assays" are a new form of molecular influenza diagnostic test with great sensitivity and specificity. NATs are used to detect certain infections (Natural Antisense Transcripts). The primary benefit of NATs is that they do not require the viability of target microorganisms and can provide data in a therapeutically relevant time range.
“Strict Laws for Mining Sector Increases Consumption of Respiratory Pathogen Testing Kits”
Because of the involuntary inhalation of silica dust, coal miners all over the world are at significant risk for non-malignant respiratory illnesses like COPD (which contains bacteria).
Nearly 53,000 people work in coal power plants in the EU, while 185,000 people work in coal mines. Regular checks of these employees are also conducted by the EU a regulatory organisation, which again increases the demand for respiratory pathogen testing kits.
In countries such as Australia, there are mining rules and regulations to check into the safety of coal miners. As part of environmental legislation, coal mining businesses must have respiratory pathogen testing kits at the workplace.
Furthermore, certain high-risk occupations, such as coal mining, are regulated by government safety regulations. As a result, these workplaces use respiratory pathogen testing kits to report workers' health quotients. This continuous demand is projected to keep the respiratory pathogen testing kits market on the rise.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Can Hinder Respiratory Pathogen Testing Kits Market Growth?
“High Product Cost & Lack of Awareness May Hamper Sales Growth of Respiratory Pathogen Testing Kits Market”
Although molecular diagnostic procedures have become an important aspect of life science research, the high cost of running molecular processes (particularly by private laboratories) may limit market growth in emerging economies. The cost of testing has risen in tandem with the advent of technological and procedural breakthroughs in biotechnology.
Patients bear the brunt of the inbound costs. As a result, global players must be on the lookout for cost-cutting opportunities. Lacks of knowledge, as well as the prevalence of a significant underdiagnosed and undertreated population, are major commercial hurdles.
Which Regional Markets are Most Profitable for Respiratory Pathogen Testing Kit Providers?
“North America Likely to Hold High Market Share Due to Rising Prevalence of Respiratory Disorders”
The most profitable markets for respiratory pathogen testing kits are still the United States and Europe. They have a combined market share of roughly 55% and are likely to maintain this trend over the coming years. Apart from Covid-19 and other existing viral, bacterial, and fungal illnesses, a sedentary lifestyle is boosting the market in these two regions.
The Asia Pacific region is also picking up steam, with a slew of local companies producing respiratory pathogen testing kits to meet the rising number of Covid-19 cases. In addition, gastrointestinal tract infections have been reported in Asia Pacific’s emerging nations, owing to people's lack of attention to food cleanliness.
Another market stimulant is air pollution. According to IQAir, Asia Pacific is home to more than 20 of the world's most polluted countries. Choking of the respiratory tract is caused by uncontrolled intake of carbon monoxide and sulphur dioxide, increasing sales of respiratory pathogen testing kits.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Analysis
Why is NAAT Technology Becoming Popular in the U.S.?
“Rising Cases of Cancer & Advanced Healthcare Facilities Fuel Demand for NAAT-based Diagnostic Testing”
Because of improved healthcare infrastructure and the increased prevalence of infectious diseases, the United States is predicted to be the largest nucleic acid amplification testing market. In the United States and around the globe, NAAT is becoming the standard of practice in the blood and plasma industry.
According to cancer.org, the United States will have 1.9 Mn new cases of cancer diagnosed in 2022, with 609,360 cancer fatalities. The demand for diagnostic tests like NAAT is expanding in response to the rising cancer burden.
According to hhs.gov, Hepatitis C is projected to affect 2.4 Mn people in the United States. Hepatitis B is predicted to affect 850,000 people in the United States. The exact figure could be as higher as 4.7 Mn or as lower as 2.5 Mn. The exact figure could be anywhere from 2.2 million and 730,000.
More than half of hepatitis patients are unaware that they have the infection. As a result, individuals are at risk of developing life-threatening liver illness and cancer, as well as unwittingly spreading the virus to others.
As a result, the country's demand for better diagnostic tests is growing, and big firms and the administration are focusing on NAAT. As a result of all the factors listed above, the market for respiratory pathogen testing kits in the U.S. is predicted to rise rapidly.
How is the Respiratory Pathogen Testing Kits Market Growing in China?
“Collaboration & Partnership Tactics to Boost Sales of Respiratory Pathogen Testing Kits”
According to a Reuters investigation of research, patent filings, and other papers, BGI Group, the world's largest genomics corporation, has collaborated with China's military on projects ranging from mass testing for respiratory viruses to brain science.
BGI's linkages to the People's Liberation Army (PLA) include research with China's top military supercomputing experts, according to an assessment of more than 40 publicly available documentation and research publications in Chinese and English. The COVID-19 pandemic began in China and quickly spread over the world. Since then, the diagnostic sector has grown at a breakneck pace.
Since the beginning of the current coronavirus pandemic, China has marketed millions of COVID-19 test kits outside of the country, including to Europe, Australia, and the United States. Thus overall all the above aspects show that china is rapidly growing its respiratory pathogen testing kits business.
Category-wise Analysis
Which Technology Contributes More towards Market Growth of Respiratory Pathogen Testing Kits?
“Nucleic Acid Amplification Test Gaining Popularity Due to its Effective Result”
For SARS-CoV-2, the virus that causes COVID-19, a Nucleic Acid Amplification Test or NAAT, is a form of a viral diagnostic test. NAATs are genetic material detectors (nucleic acids). SARS-CoV-2 NAATs precisely identify the RNA (ribonucleic acid) sequences that make up the virus's genetic material.
For SARS-CoV-2 test specimens from the upper or lower respiratory tracts, NAATs are used. When testing for SARS-CoV-2, the type of specimen taken is determined by the test being conducted and the manufacturer's recommendations.
The rising prevalence of contagious diseases, increasing need for better diagnostic measures, and increased investment in the development of novel biotechnological diagnostic procedures are all driving the expansion of nucleic acid amplification testing technology. At present, nucleic acid amplification testing is expected to account for 44.6% of the global market share.
An immunoassay is a test that uses antibodies or immunoglobulin to assess the concentration of a macromolecule in a solution. Analyte refers to the macromolecule that has been detected. For medical and research reasons, immunoassay is used to determine the number of solutes in serum and urine. It is also used to check the correctness of results acquired in qualitative, quantitative, and radioactive procedures. Immunoassays with diagnostic accuracy are utilised to accelerate the rate of reaction.
Increasing prevalence of chronic and infectious diseases, as well as the usage of immunoassays in oncology, is driving the global immunoassay trade forward. In addition, immunoassays technological breakthroughs and sensitivity, cost-effectiveness, and speedy analysis contribute to their rise.
In 2022, immunoassays technology is predicted to hold 31.3% of the global market share, while other technologies are likely to account for 24.1% of the global market share.
Competitive Landscape
Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Hoffmann-La Roche Ltd., bioMérieux Inc., Altona Diagnostics, and MyLab are some of the major participants in the respiratory pathogen testing kits market.
Leading respiratory pathogen testing equipment manufacturers are concentrating their efforts on developing unique testing kits that will aid in obtaining results quickly. They're investing heavily to get a competitive advantage over one another.
New products are being introduced into the respiratory pathogen testing kits market, as well as expansion into new geographies.
- Philips expanded its ultrasound offering with additional strong imaging tools and features for Radiology in November 2021, boosting diagnostic assurance and workflow efficiency.
Respiratory Pathogen Testing Kits Industry Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2030 |
|
Historical Data Available for |
2015-2021 |
|
Market Analysis |
US$ Bn for Value, Units for Volume |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments of Respiratory Pathogen Testing Kits Industry Survey
Respiratory Pathogen Testing Kits Market by Product:
- RT PCR Kits
- DFA Kits
- ELISA Kits
- Others
Respiratory Pathogen Testing Kits Market by Infection/Symptom:
- Matrix
- Enterovirus Infection
- Human Coronavirus Infection
- Influenza Virus Infection
- Respiratory Syncytial Virus Infection
- Rhinovirus Infection
- Pneumonia
Respiratory Pathogen Testing Kits Market by Technology:
- NAAT (Nucleic Acid Amplification)
- Immunoassays
- Others
Respiratory Pathogen Testing Kits Market by End User:
- Hospitals
- Diagnostic Centers
- Speciality Clinics
Respiratory Pathogen Testing Kits Market by Region:
- North America Respiratory Pathogen Testing Kits Market
- Latin America Respiratory Pathogen Testing Kits Market
- Europe Respiratory Pathogen Testing Kits Market
- East Asia Respiratory Pathogen Testing Kits Market
- South Asia & Pacific Respiratory Pathogen Testing Kits Market
- Middle East & Africa (MEA) Respiratory Pathogen Testing Kits Market
Frequently Asked Questions
The global respiratory pathogen testing kits market is estimated to expand at a CAGR of 6.1% through 2030.
The global respiratory pathogen testing kits market is currently worth US$ 3.85 Bn.
Key respiratory pathogen testing kit manufacturers are Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Hoffmann-La Roche Ltd., bioMérieux Inc., Altona Diagnostics, and MyLab.
By 2030, respiratory pathogen testing kit demand is anticipated to reach a valuation of US$ 6.16 Bn.
Market growth is being witnessed due to factors such as rising prevalence of chronic and respiratory disorders, as well as increasing investments in research and development activities in this field.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development Trends
4. Key Success Factors
4.1. New Product Launches
4.2. Key Strategies Followed By Manufacturers
4.3. Pipeline Assessment & Opportunity Analysis
5. Market Context
5.1. Epidemiology of Severe Acute Respiratory Syndrome, By Country
5.2. Regulatory Scenario
5.3. Product Adoption / Usage Analysis
5.4. Reimbursement Scenario
5.5. Pipeline Analysis
5.6. Value Chain Analysis
5.7. Global Average Pricing Analysis Benchmark
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By Indications
6.4.3. Revenue By Country
6.5. 2022 Market Scenario
6.6. Quarter by Quarter Forecast
6.7. Projected recovery Quarter
6.8. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Respiratory Pathogen Testing Market Demand Analysis 2015-2021`` and Forecast, 2022-2030
7.1. Historical Market Volume (Units) Analysis, 2015-2021``
7.2. Current and Future Market Volume (Units) Projections, 2022-2030
7.3. Y-o-Y Growth Trend Analysis
8. Global Respiratory Pathogen Testing Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product Type
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Respiratory Pathogen Testing Market Demand (in Value or Size in US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030
9.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Market Background
10.1. Macro-Economic Factors
10.1.1. Global GDP Growth Outlook
10.1.2. Global Healthcare Outlook
10.1.3. Per Capita Healthcare Expenditure Outlook
10.2. Forecast Factors - Relevance & Impact
10.2.1. Increasing Incidence of Respiratory Infections
10.2.2. Recent Outbreak of Corona Virus
10.2.3. Increasing Healthcare Expenditure
10.2.4. Growing Demand of Treatment
10.3. Market Dynamics
10.3.1. Drivers
10.3.2. Restraints
10.3.3. Opportunity Analysis
11. Global Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030, By Products
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Products, 2015–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Products, 2022-2030
11.3.1. RT PCR kits
11.3.2. DFA Kits
11.3.3. ELISA Kits
11.3.4. Others
11.3.5. Market Attractiveness Analysis By Products
12. Global Respiratory Pathogen Testing Market Analysis 2015-2021`` and Forecast 2022-2030, by Indications
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Analysis By Indications, 2015 - 2021``
12.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Indications, 2022- 2030
12.3.1. Enterovirus Infection
12.3.2. Human Coronavirus Infection
12.3.3. Influenza Virus Infection
12.3.4. Respiratory Syncytial Virus Infection
12.3.5. Rhinovirus Infection
12.3.6. Pneumonia
12.3.7. Others
12.4. Market Attractiveness Analysis By Indications
13. Global Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030, by Technology
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) and Analysis By Technology, 2015 - 2021``
13.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Technology, 2022 - 2030
13.3.1. NAAT (Nucliec Acid Amplification)
13.3.2. Immunoassay
13.3.3. Others
13.4. Market Attractiveness Analysis By Technology
14. Global Respiratory Pathogen Testing Market Analysis 2015-2021`` and Forecast 2022-2030, by End User
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) and Analysis By End User, 2015 - 2021``
14.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By End User, 2022 - 2030
14.3.1. Hospitals
14.3.2. Diagnostic Centers
14.3.3. Speciality Clinics
14.4. Market Attractiveness Analysis By End User
15. Global Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030, by Region
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2021
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. East Asia
15.3.5. South Asia
15.3.6. Oceania
15.3.7. Middle East and Africa (MEA)
15.4. Market Attractiveness Analysis By Region
16. North America Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
16.3.1. By Country
16.3.1.1. U.S.
16.3.1.2. Canada
16.3.2. By Products
16.3.3. By Technique
16.3.4. By Indications
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Products
16.4.3. By Technique
16.4.4. By Indications
16.4.5. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. Latin America Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
17.3.1. By Country
17.3.1.1. Brazil
17.3.1.2. Mexico
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Products
17.3.3. By Technique
17.3.4. By Strain
17.3.5. By Indications
17.3.6. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Products
17.4.3. By Technique
17.4.4. By Indications
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Europe Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. Italy
18.3.1.3. France
18.3.1.4. U.K.
18.3.1.5. Spain
18.3.1.6. BENELUX
18.3.1.7. Russia
18.3.1.8. Rest of Europe
18.3.2. By Products
18.3.3. By Technique
18.3.4. By Indications
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Products
18.4.3. By Technique
18.4.4. By Indications
18.4.5. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
19. South Asia Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Thailand
19.3.1.3. Indonesia
19.3.1.4. Malaysia
19.3.1.5. Rest of South Asia
19.3.2. By Products
19.3.3. By Technique
19.3.4. By Indications
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Products
19.4.3. By Technique
19.4.4. By Indications
19.4.5. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
20. East Asia Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
20.3.1. By Country
20.3.1.1. China
20.3.1.2. Japan
20.3.1.3. South Korea
20.3.2. By Products
20.3.3. By Technique
20.3.4. By Indications
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Products
20.4.3. By Technique
20.4.4. By Indications
20.4.5. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
21. Oceania Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
21.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Products
21.3.3. By Technique
21.3.4. By Indications
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Products
21.4.3. By Technique
21.4.4. By Indications
21.4.5. By End User
21.5. Market Trends
21.6. Key Market Participants - Intensity Mapping
21.7. Drivers and Restraints - Impact Analysis
22. Middle East and Africa Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030
22.1. Introduction
22.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021
22.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030
22.3.1. By Country
22.3.1.1. GCC Countries
22.3.1.2. Turkey
22.3.1.3. Northern Africa
22.3.1.4. South Africa
22.3.1.5. Rest of Middle East and Africa
22.3.2. By Products
22.3.3. By Technique
22.3.4. By Indications
22.3.5. By End User
22.4. Market Attractiveness Analysis
22.4.1. By Country
22.4.2. By Products
22.4.3. By Technique
22.4.4. By Indications
22.4.5. By End User
22.5. Market Trends
22.6. Key Market Participants - Intensity Mapping
22.7. Drivers and Restraints - Impact Analysis
23. Key and Emerging Countries Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030
23.1. Introduction
23.1.1. Market Value Proportion Analysis, By Key Countries
23.1.2. Global Vs. Country Growth Comparison
23.2. U.S. Respiratory Pathogen Testing Market Analysis
23.2.1. By Products
23.2.2. By Technique
23.2.3. By Indications
23.2.4. By End User
23.3. Canada Respiratory Pathogen Testing Market Analysis
23.3.1. By Products
23.3.2. By Technique
23.3.3. By Indications
23.3.4. By End User
23.4. Mexico Respiratory Pathogen Testing Market Analysis
23.4.1. By Products
23.4.2. By Technique
23.4.3. By Indications
23.4.4. By End User
23.5. Brazil Respiratory Pathogen Testing Market Analysis
23.5.1. By Products
23.5.2. By Technique
23.5.3. By Indications
23.5.4. By End User
23.6. U.K. Respiratory Pathogen Testing Market Analysis
23.6.1. By Products
23.6.2. By Technique
23.6.3. By Indications
23.6.4. By End User
23.7. Germany Respiratory Pathogen Testing Market Analysis
23.7.1. By Products
23.7.2. By Technique
23.7.3. By Indications
23.7.4. By End User
23.8. France Respiratory Pathogen Testing Market Analysis
23.8.1. By Products
23.8.2. By Technique
23.8.3. By Indications
23.8.4. By End User
23.9. Italy Respiratory Pathogen Testing Market Analysis
23.9.1. By Products
23.9.2. By Technique
23.9.3. By Indications
23.9.4. By End User
23.10. Spain Respiratory Pathogen Testing Market Analysis
23.10.1. By Products
23.10.2. By Technique
23.10.3. By Indications
23.10.4. By End User
23.11. Russia Respiratory Pathogen Testing Market Analysis
23.11.1. By Products
23.11.2. By Technique
23.11.3. By Indications
23.11.4. By End User
23.12. China Respiratory Pathogen Testing Market Analysis
23.12.1. By Products
23.12.2. By Technique
23.12.3. By Indications
23.12.4. By End User
23.13. Japan Respiratory Pathogen Testing Market Analysis
23.13.1. By Products
23.13.2. By Technique
23.13.3. By Indications
23.13.4. By End User
23.14. South Korea Respiratory Pathogen Testing Market Analysis
23.14.1. By Products
23.14.2. By Technique
23.14.3. By Indications
23.14.4. By End User
23.15. India Respiratory Pathogen Testing Market Analysis
23.15.1. By Products
23.15.2. By Technique
23.15.3. By Indications
23.15.4. By End User
23.16. ASEAN Respiratory Pathogen Testing Market Analysis
23.16.1. By Products
23.16.2. By Technique
23.16.3. By Indications
23.16.4. By End User
23.17. Australia Respiratory Pathogen Testing Market Analysis
23.17.1. By Products
23.17.2. By Technique
23.17.3. By Indications
23.17.4. By End User
23.18. New Zealand Respiratory Pathogen Testing Market Analysis
23.18.1. By Products
23.18.2. By Technique
23.18.3. By Indications
23.18.4. By End User
23.19. GCC Countries Respiratory Pathogen Testing Market Analysis
23.19.1. By Products
23.19.2. By Technique
23.19.3. By Indications
23.19.4. By End User
23.20. South Africa Respiratory Pathogen Testing Market Analysis
23.20.1. By Products
23.20.2. By Technique
23.20.3. By Indications
23.20.4. By End User
24. Market Structure Analysis
24.1. Market Analysis by Tier of Companies
24.2. Market Share Analysis
24.3. Market Presence Analysis
24.3.1. By Regional footprint of Players
24.3.2. Product foot print by Players
24.3.3. Channel Foot Print by Players
25. Competition Analysis
25.1. Competition Dashboard
25.2. Competition Benchmarking
25.3. Competition Deep Dive (Tentative List)
25.3.1. Hoffmann-La Roche Inc.
25.3.1.1. Overview
25.3.1.2. Product Portfolio
25.3.1.3. Profitability by Market Segments (Product/Channel/Region)
25.3.1.4. Sales Footprint
25.3.1.5. Strategy Overview
25.3.1.5.1. Marketing Strategy
25.3.1.5.2. Product Strategy
25.3.1.5.3. Channel Strategy
25.3.2. Seegene Inc
25.3.2.1. Overview
25.3.2.2. Product Portfolio
25.3.2.3. Profitability by Market Segments (Product/Channel/Region)
25.3.2.4. Sales Footprint
25.3.2.5. Strategy Overview
25.3.2.5.1. Marketing Strategy
25.3.2.5.2. Product Strategy
25.3.2.5.3. Channel Strategy
25.3.3. Fast Track Diagnostics Ltd
25.3.3.1. Overview
25.3.3.2. Product Portfolio
25.3.3.3. Profitability by Market Segments (Product/Channel/Region)
25.3.3.4. Sales Footprint
25.3.3.5. Strategy Overview
25.3.3.5.1. Marketing Strategy
25.3.3.5.2. Product Strategy
25.3.3.5.3. Channel Strategy
25.3.4. PathoFinder BV
25.3.4.1. Overview
25.3.4.2. Product Portfolio
25.3.4.3. Profitability by Market Segments (Product/Channel/Region)
25.3.4.4. Sales Footprint
25.3.4.5. Strategy Overview
25.3.4.5.1. Marketing Strategy
25.3.4.5.2. Product Strategy
25.3.4.5.3. Channel Strategy
25.3.5. Daan Gene Co Ltd
25.3.5.1. Overview
25.3.5.2. Product Portfolio
25.3.5.3. Profitability by Market Segments (Product/Channel/Region)
25.3.5.4. Sales Footprint
25.3.5.5. Strategy Overview
25.3.5.5.1. Marketing Strategy
25.3.5.5.2. Product Strategy
25.3.5.5.3. Channel Strategy
25.3.6. Veredus Laboratories Pte Ltd
25.3.6.1. Overview
25.3.6.2. Product Portfolio
25.3.6.3. Profitability by Market Segments (Product/Channel/Region)
25.3.6.4. Sales Footprint
25.3.6.5. Strategy Overview
25.3.6.5.1. Marketing Strategy
25.3.6.5.2. Product Strategy
25.3.6.5.3. Channel Strategy
25.3.7. True Health Diagnostics LLC
25.3.7.1. Overview
25.3.7.2. Product Portfolio
25.3.7.3. Profitability by Market Segments (Product/Channel/Region)
25.3.7.4. Sales Footprint
25.3.7.5. Strategy Overview
25.3.7.5.1. Marketing Strategy
25.3.7.5.2. Product Strategy
25.3.7.5.3. Channel Strategy
25.3.8. Genetic Signatures Ltd
25.3.8.1. Overview
25.3.8.2. Product Portfolio
25.3.8.3. Profitability by Market Segments (Product/Channel/Region)
25.3.8.4. Sales Footprint
25.3.8.5. Strategy Overview
25.3.8.5.1. Marketing Strategy
25.3.8.5.2. Product Strategy
25.3.8.5.3. Channel Strategy
25.3.9. Beijing Baicare BioTechnique Co Ltd
25.3.9.1. Overview
25.3.9.2. Product Portfolio
25.3.9.3. Profitability by Market Segments (Product/Channel/Region)
25.3.9.4. Sales Footprint
25.3.9.5. Strategy Overview
25.3.9.5.1. Marketing Strategy
25.3.9.5.2. Product Strategy
25.3.9.5.3. Channel Strategy
25.3.10. Cue Health Inc
25.3.10.1. Overview
25.3.10.2. Product Portfolio
25.3.10.3. Profitability by Market Segments (Product/Channel/Region)
25.3.10.4. Sales Footprint
25.3.10.5. Strategy Overview
25.3.10.5.1. Marketing Strategy
25.3.10.5.2. Product Strategy
25.3.10.5.3. Channel Strategy
25.3.11. Siemens Healthineers AG
25.3.11.1. Overview
25.3.11.2. Product Portfolio
25.3.11.3. Profitability by Market Segments (Product/Channel/Region)
25.3.11.4. Sales Footprint
25.3.11.5. Strategy Overview
25.3.11.5.1. Marketing Strategy
25.3.11.5.2. Product Strategy
25.3.11.5.3. Channel Strategy
25.3.12. Abbott Laboratories
25.3.12.1. Overview
25.3.12.2. Product Portfolio
25.3.12.3. Profitability by Market Segments (Product/Channel/Region)
25.3.12.4. Sales Footprint
25.3.12.5. Strategy Overview
25.3.12.5.1. Marketing Strategy
25.3.12.5.2. Product Strategy
25.3.12.5.3. Channel Strategy
25.3.13. Sysmex Corp
25.3.13.1. Overview
25.3.13.2. Product Portfolio
25.3.13.3. Profitability by Market Segments (Product/Channel/Region)
25.3.13.4. Sales Footprint
25.3.13.5. Strategy Overview
25.3.13.5.1. Marketing Strategy
25.3.13.5.2. Product Strategy
25.3.13.5.3. Channel Strategy
25.3.14. Beckman Coulter Inc
25.3.14.1. Overview
25.3.14.2. Product Portfolio
25.3.14.3. Profitability by Market Segments (Product/Channel/Region)
25.3.14.4. Sales Footprint
25.3.14.5. Strategy Overview
25.3.14.5.1. Marketing Strategy
25.3.14.5.2. Product Strategy
25.3.14.5.3. Channel Strategy
25.3.15. Danaher Corp
25.3.15.1. Overview
25.3.15.2. Product Portfolio
25.3.15.3. Profitability by Market Segments (Product/Channel/Region)
25.3.15.4. Sales Footprint
25.3.15.5. Strategy Overview
25.3.15.5.1. Marketing Strategy
25.3.15.5.2. Product Strategy
25.3.15.5.3. Channel Strategy
25.3.16. Bio-Rad Laboratories Inc
25.3.16.1. Overview
25.3.16.2. Product Portfolio
25.3.16.3. Profitability by Market Segments (Product/Channel/Region)
25.3.16.4. Sales Footprint
25.3.16.5. Strategy Overview
25.3.16.5.1. Marketing Strategy
25.3.16.5.2. Product Strategy
25.3.16.5.3. Channel Strategy
25.3.17. Thermo Fisher Scientific Inc
25.3.17.1. Overview
25.3.17.2. Product Portfolio
25.3.17.3. Profitability by Market Segments (Product/Channel/Region)
25.3.17.4. Sales Footprint
25.3.17.5. Strategy Overview
25.3.17.5.1. Marketing Strategy
25.3.17.5.2. Product Strategy
25.3.17.5.3. Channel Strategy
25.3.18. Qiagen NV
25.3.18.1. Overview
25.3.18.2. Product Portfolio
25.3.18.3. Profitability by Market Segments (Product/Channel/Region)
25.3.18.4. Sales Footprint
25.3.18.5. Strategy Overview
25.3.18.5.1. Marketing Strategy
25.3.18.5.2. Product Strategy
25.3.18.5.3. Channel Strategy
25.3.19. bioMerieux SA
25.3.19.1. Overview
25.3.19.2. Product Portfolio
25.3.19.3. Profitability by Market Segments (Product/Channel/Region)
25.3.19.4. Sales Footprint
25.3.19.5. Strategy Overview
25.3.19.5.1. Marketing Strategy
25.3.19.5.2. Product Strategy
25.3.19.5.3. Channel Strategy
25.3.20. Horiba Ltd
25.3.20.1. Overview
25.3.20.2. Product Portfolio
25.3.20.3. Profitability by Market Segments (Product/Channel/Region)
25.3.20.4. Sales Footprint
25.3.20.5. Strategy Overview
25.3.20.5.1. Marketing Strategy
25.3.20.5.2. Product Strategy
25.3.20.5.3. Channel Strategy
26. Assumptions and Acronyms Used
27. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type
Table 02: Global Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication
Table 03: Global Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User
Table 04: Global Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Region
Table 05: North America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country
Table 06: North America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type
Table 07: North America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication
Table 08: North America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User
Table 09: Latin America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country
Table 10: Latin America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type
Table 11: Latin America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication
Table 12: Latin America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User
Table 13: Europe Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country
Table 14: Europe Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type
Table 15: Europe Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication
Table 16: Europe Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User
Table 17: South Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country
Table 18: South Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type
Table 19: South Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication
Table 20: South Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User
Table 21: East Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country
Table 22: East Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type
Table 23: East Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication
Table 24: East Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User
Table 25: Oceania Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country
Table 26: Oceania Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type
Table 27: Oceania Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication
Table 28: Oceania Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User
Table 29: Middle East & Africa Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country
Table 30: Middle East & Africa Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type
Table 31: Middle East & Africa Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication
Table 32: Middle East & Africa Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021
Figure 02: Global Respiratory Pathogen Testing kits Market Share, By Product Type (2021)
Figure 03: Global Respiratory Pathogen Testing kits Market Share, By Indication (2021)
Figure 04: Global Respiratory Pathogen Testing kits Market Share, By End User (2021)
Figure 05: Global Respiratory Pathogen Testing kits Market Y-o-Y Analysis (%), By Product Type, 2022–2030
Figure 06: Global Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030
Figure 07: Global Respiratory Pathogen Testing kits Market Share Analysis (%), By Indication, 2022 & 2030
Figure 08: Global Respiratory Pathogen Testing kits Market Y-o-Y Analysis (%), By Indication, 2022–2030
Figure 09: Global Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030
Figure 10: Global Respiratory Pathogen Testing kits Market Share Analysis (%), By End User, 2022 & 2030
Figure 11: Global Respiratory Pathogen Testing kits Market Y-o-Y Analysis (%), By End User, 2022–2030
Figure 12: Global Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030
Figure 13: Global Respiratory Pathogen Testing kits Market Share Analysis (%), By Region Type, 2022 & 2030
Figure 14: Global Respiratory Pathogen Testing kits Market Y-o-Y Analysis (%), By Region Type, 2022–2030
Figure 15: Global Respiratory Pathogen Testing kits Market Attractiveness Analysis By Region, 2022–2030
Figure 16: North America Respiratory Pathogen Testing kits Market Split By Country 2022 (E)
Figure 17: North America Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)
Figure 18: North America Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)
Figure 19: North America Respiratory Pathogen Testing kits Market Split By End User 2022 (E)
Figure 20: North America Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021
Figure 21: North America Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030
Figure 22: North America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030
Figure 23: North America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030
Figure 24: North America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030
Figure 25: North America Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030
Figure 26: Latin America Respiratory Pathogen Testing kits Market Split By Country 2022 (E)
Figure 27: Latin America Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)
Figure 28: Latin America Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)
Figure 29: Latin America Respiratory Pathogen Testing kits Market Split By End User 2022 (E)
Figure 30: Latin America Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021
Figure 31: Latin America Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030
Figure 32: Latin America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030
Figure 33: Latin America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030
Figure 34: Latin America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030
Figure 35: Latin America Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030
Figure 36: Europe Respiratory Pathogen Testing kits Market Split By Country 2022 (E)
Figure 37: Europe Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)
Figure 38: Europe Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)
Figure 39: Europe Respiratory Pathogen Testing kits Market Split By End User 2022 (E)
Figure 40: Europe Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021
Figure 41: Europe Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030
Figure 42: Europe Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030
Figure 43: Europe Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030
Figure 44: Europe Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030
Figure 45: Europe Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030
Figure 46: South Asia Respiratory Pathogen Testing kits Market Split By Country 2022 (E)
Figure 47: South Asia Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)
Figure 48: South Asia Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)
Figure 49: South Asia Respiratory Pathogen Testing kits Market Split By End User 2022 (E)
Figure 50: South Asia Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021
Figure 51: South Asia Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030
Figure 52: South Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030
Figure 53: South Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030
Figure 54: South Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030
Figure 55: South Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030
Figure 56: East Asia Respiratory Pathogen Testing kits Market Split By Country 2022 (E)
Figure 57: East Asia Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)
Figure 58: East Asia Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)
Figure 59: East Asia Respiratory Pathogen Testing kits Market Split By End User 2022 (E)
Figure 60: East Asia Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021
Figure 61: East Asia Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030
Figure 62: East Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030
Figure 63: East Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030
Figure 64: East Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030
Figure 65: East Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030
Figure 66: Oceania Respiratory Pathogen Testing kits Market Split By Country 2022 (E)
Figure 67: Oceania Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)
Figure 68: Oceania Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)
Figure 69: Oceania Respiratory Pathogen Testing kits Market Split By End User 2022 (E)
Figure 70: Oceania Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021
Figure 71: Oceania Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030
Figure 72: Oceania Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030
Figure 73: Oceania Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030
Figure 74: Oceania Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030
Figure 75: Oceania Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030
Figure 76: Middle East & Africa Respiratory Pathogen Testing kits Market Split By Country 2022 (E)
Figure 77: Middle East & Africa Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)
Figure 78: Middle East & Africa Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)
Figure 79: Middle East & Africa Respiratory Pathogen Testing kits Market Split By End User 2022 (E)
Figure 80: Middle East & Africa Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021
Figure 81: Middle East & Africa Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030
Figure 82: Middle East & Africa Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030
Figure 83: Middle East & Africa Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030
Figure 84: Middle East & Africa Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030
Figure 85: Middle East & Africa Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030
Figure 86: U.S Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 87: U.S. Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 88: U.S. Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 89: U.S. Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 90: Global Vs. U.S Growth Comparison
Figure 91: Canada Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 92: Canada Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 93: Canada Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 94: Canada Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 95: Global Vs. Canada Growth Comparison
Figure 96: Brazil Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 97: Brazil Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 98: Brazil Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 99: Brazil Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 100: Global Vs. Brazil Growth Comparison
Figure 101: Mexico Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 102: Mexico Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 103: Mexico Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 104: Mexico Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 105: Global Vs. Mexico Growth Comparison
Figure 106: U.K. Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 107: U.K. Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 108: U.K. Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 109: U.K. Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 110: Global Vs. U.K. Growth Comparison
Figure 111: Germany Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 112: Germany Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 113: Germany Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 114: Germany Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 115: Global Vs. Germany Growth Comparison
Figure 116: France Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 117: France Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 118: France Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 119: France Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 120: Global Vs. France Growth Comparison
Figure 121: Italy Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 122: Italy Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 123: Italy Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 124: Italy Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 125: Global Vs. Italy Growth Comparison
Figure 126: Spain Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 127: Spain Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 128: Spain Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 129: Spain Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 130: Global Vs. Spain Growth Comparison
Figure 131: Russia Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 132: Russia Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 133: Russia Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 134: Russia Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 135: Global Vs. Russia Growth Comparison
Figure 136: Japan Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 137: Japan Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 138: Japan Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 139: Japan Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 140: Global Vs. Japan Growth Comparison
Figure 141: South Korea Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 142: South Korea Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 143: South Korea Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 144: South Korea Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 145: Global Vs. South Korea Growth Comparison
Figure 146: India Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 147: India Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 148: India Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 149: India Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 150: Global Vs. India Growth Comparison
Figure 151: Australia Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 152: Australia Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 153: Australia Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 154: Australia Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 155: Global Vs. Australia Growth Comparison
Figure 156: New Zealand Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 157: New Zealand Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 158: New Zealand Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 159: New Zealand Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 160: Global Vs. New Zealand Growth Comparison
Figure 161: GCC Countries Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 162: GCC Countries Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 163: GCC Countries Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 164: GCC Countries Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 165: Global Vs. GCC Countries Growth Comparison
Figure 166: Turkey Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 167: Turkey Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 168: Turkey Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 169: Turkey Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 170: Global Vs. Turkey Growth Comparison
Figure 171: South Africa Respiratory Pathogen Testing kits Market Value Proportion Analysis
Figure 172: South Africa Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030
Figure 173: South Africa Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030
Figure 174: South Africa Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030
Figure 175: Global Vs. South Africa Growth Comparison
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
